176 related articles for article (PubMed ID: 21342725)
1. [Thymic uptake of 18FFDG following radioiodine ablation therapy].
Albalá González MD; Martínez Gimeno E; Cárdenas Negro C; Allende Riera A; Cabello García D; De Sequera Rahola M; Uña Gorospe JA
Rev Esp Med Nucl; 2011; 30(5):314-6. PubMed ID: 21342725
[TBL] [Abstract][Full Text] [Related]
2. Thyroid cancer presenting as a PET incidentaloma in a patient with concomitant breast cancer metastases to the thyroid.
Leboeuf R; Bénard F; Langlois MF
Clin Nucl Med; 2006 Jul; 31(7):382-5. PubMed ID: 16785803
[TBL] [Abstract][Full Text] [Related]
3. [Occult papillary thyroid carcinoma in thyroglossal cyst diagnosed by (18)FDG PET/CT scan].
Serrano Vicente J; Infante Torre JR; Rayo Madrid JI; García Bernardo L; Domínguez Grande ML; Durán Barquero C; Sánchez Sánchez R
Rev Esp Med Nucl Imagen Mol; 2012; 31(4):229-30. PubMed ID: 22980131
[No Abstract] [Full Text] [Related]
4. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.
Lind P; Kohlfürst S
Semin Nucl Med; 2006 Jul; 36(3):194-205. PubMed ID: 16762610
[TBL] [Abstract][Full Text] [Related]
5. Fibroelastic pseudotumor elastofibroma dorsi detected by
Oporto M; Cepa F; Orta N; Rubí S; Navalón H; Peña C
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(1):46-49. PubMed ID: 28522155
[TBL] [Abstract][Full Text] [Related]
6. [Pathological thyroid uptake in Cushing's syndrome: an unexpected finding].
Civantos Modino S; Montaño Martínez J; Pavón de Paz I; Guijarro de Armas G; Monereo Megías S
Endocrinol Nutr; 2011; 58(6):315-7. PubMed ID: 21497569
[No Abstract] [Full Text] [Related]
7. Effect of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography-guided management of suspected recurrent papillary thyroid carcinoma: long-term follow-up with tumour marker responses.
Dennis K; Hay JH; Wilson DC
Clin Oncol (R Coll Radiol); 2012 Dec; 24(10):e168-72. PubMed ID: 22944464
[TBL] [Abstract][Full Text] [Related]
8. Thymus accumulation of I-131 after therapeutic dose for thyroid carcinoma.
Muratet JP; Giraud P
Clin Nucl Med; 1996 Sep; 21(9):736-7. PubMed ID: 8879880
[No Abstract] [Full Text] [Related]
9. Does recombinant human thyrotropin-stimulated positron emission tomography with [18F]fluoro-2-deoxy-D-glucose improve detection of recurrence of well-differentiated thyroid carcinoma in patients with low serum thyroglobulin?
Vera P; Kuhn-Lansoy C; Edet-Sanson A; Hapdey S; Modzelewski R; Hitzel A; d'Anjou J; Basuyau JP
Thyroid; 2010 Jan; 20(1):15-23. PubMed ID: 20017617
[TBL] [Abstract][Full Text] [Related]
10. Detection of unsuspected metachronous second primary malignancy giving rise to supposed "non-iodine avid metastasis" in differentiated thyroid carcinoma.
Basu S; Nair N; Shet T
Clin Nucl Med; 2007 Aug; 32(8):655-8. PubMed ID: 17667446
[TBL] [Abstract][Full Text] [Related]
11. Focal thyroid incidentalomas identified with whole-body FDG-PET warrant further investigation.
Prichard RS; Cotter M; Evoy D; Gibbons D; Collins C; McDermott E; Skehan S
Ir Med J; 2011 Jun; 104(6):177-9. PubMed ID: 22111394
[TBL] [Abstract][Full Text] [Related]
12. Focal uptake of (18)F-fluorodeoxyglucose by thyroid in patients with nonthyroidal head and neck cancers.
Nam SY; Roh JL; Kim JS; Lee JH; Choi SH; Kim SY
Clin Endocrinol (Oxf); 2007 Jul; 67(1):135-9. PubMed ID: 17465995
[TBL] [Abstract][Full Text] [Related]
13. Intense 18-fluorodeoxyglucose uptake by the thymus on PET scan does not necessarily herald recurrence of thyroid carcinoma.
Godart V; Weynand B; Coche E; De Nayer P; Daumerie C
J Endocrinol Invest; 2005 Dec; 28(11):1024-8. PubMed ID: 16483183
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of focal and diffuse thyroid diseases identified by (18)F-fluorodeoxyglucose positron emission tomography.
Salvatori M; Melis L; Castaldi P; Maussier ML; Rufini V; Perotti G; Rubello D
Biomed Pharmacother; 2007 Sep; 61(8):488-93. PubMed ID: 17604940
[TBL] [Abstract][Full Text] [Related]
15. [Papillary thyroid carcinoma synchronous with breast cancer: an incidental finding in an (18)F-FDG PET-CT study carried out in a search for occult breast cancer].
Banzo J; Ubieto MA; González C; Razola P; Tardín L; Andrés A; Santapau A; Parra A; Rambalde EF; Prats E
Rev Esp Med Nucl Imagen Mol; 2012; 31(4):213-5. PubMed ID: 23067689
[TBL] [Abstract][Full Text] [Related]
16. (18)F-FDG PET discovered an elusive cervical inflammatory pseudotumor associated with a papillary thyroid cancer.
Modesto J; Gardeazabal I; Santos AM; Galofré JC
Endocrinol Nutr; 2014; 61(6):338-40. PubMed ID: 24721020
[No Abstract] [Full Text] [Related]
17. Esophageal diverticulum presenting as metastatic thyroid mass on iodine-131 scintigraphy.
Rashid K; Johns W; Chasse K; Walker M; Gupta SM
Clin Nucl Med; 2006 Jul; 31(7):405-8. PubMed ID: 16785810
[No Abstract] [Full Text] [Related]
18. Thymus uptake of 131I in patients with differentiated thyroid carcinoma: Three different case scenarios and patterns of uptake and the importance of its recognition in thyroid cancer practice.
Abhyankar A; Basu S
J Cancer Res Ther; 2015; 11(3):648. PubMed ID: 26458613
[TBL] [Abstract][Full Text] [Related]
19. Correlation of 18F-FDG PET/CT findings with histopathological results in differentiated thyroid cancer patients who have increased thyroglobulin or antithyroglobulin antibody levels and negative 131I whole-body scan results.
Ozkan E; Aras G; Kucuk NO
Clin Nucl Med; 2013 May; 38(5):326-31. PubMed ID: 23486319
[TBL] [Abstract][Full Text] [Related]
20. Role of [(18)F]-fluorodeoxy-D-glucose positron emission tomography and computed tomography in the early detection of persistent/recurrent thyroid carcinoma in intermediate-to-high risk patients following initial radioactive iodine ablation therapy.
Kim MH; O JH; Ko SH; Bae JS; Lim DJ; Kim SH; Baek KH; Lee JM; Kang MI; Cha BY; Lee KW
Thyroid; 2012 Feb; 22(2):157-64. PubMed ID: 22224820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
